Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders

Darren J Baker, Tobias Wijshake, Tamar Tchkonia, Nathan K LeBrasseur, Bennett G. Childs, Bart Van De Sluis, James L Kirkland, Jan Van Deursen

Research output: Contribution to journalArticle

1296 Citations (Scopus)

Abstract

Advanced age is the main risk factor for most chronic diseases and functional deficits in humans, but the fundamental mechanisms that drive ageing remain largely unknown, impeding the development of interventions that might delay or prevent age-related disorders and maximize healthy lifespan. Cellular senescence, which halts the proliferation of damaged or dysfunctional cells, is an important mechanism to constrain the malignant progression of tumour cells. Senescent cells accumulate in various tissues and organs with ageing and have been hypothesized to disrupt tissue structure and function because of the components they secrete. However, whether senescent cells are causally implicated in age-related dysfunction and whether their removal is beneficial has remained unknown. To address these fundamental questions, we made use of a biomarker for senescence, p16Ink4a, to design a novel transgene, INK-ATTAC, for inducible elimination of p16Ink4a-positive senescent cells upon administration of a drug. Here we show that in the BubR1 progeroid mouse background, INK-ATTAC removes p16Ink4a-positive senescent cells upon drug treatment. In tissues-such as adipose tissue, skeletal muscle and eye-in which p16Ink4a contributes to the acquisition of age-related pathologies, life-long removal of p16Ink4a-expressing cells delayed onset of these phenotypes. Furthermore, late-life clearance attenuated progression of already established age-related disorders. These data indicate that cellular senescence is causally implicated in generating age-related phenotypes and that removal of senescent cells can prevent or delay tissue dysfunction and extend healthspan.

Original languageEnglish (US)
Pages (from-to)232-236
Number of pages5
JournalNature
Volume479
Issue number7372
DOIs
StatePublished - Nov 10 2011

Fingerprint

Cell Aging
Phenotype
Transgenes
Pharmaceutical Preparations
Adipose Tissue
Skeletal Muscle
Chronic Disease
Biomarkers
Pathology

ASJC Scopus subject areas

  • General

Cite this

Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders. / Baker, Darren J; Wijshake, Tobias; Tchkonia, Tamar; LeBrasseur, Nathan K; Childs, Bennett G.; Van De Sluis, Bart; Kirkland, James L; Van Deursen, Jan.

In: Nature, Vol. 479, No. 7372, 10.11.2011, p. 232-236.

Research output: Contribution to journalArticle

Baker, Darren J ; Wijshake, Tobias ; Tchkonia, Tamar ; LeBrasseur, Nathan K ; Childs, Bennett G. ; Van De Sluis, Bart ; Kirkland, James L ; Van Deursen, Jan. / Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders. In: Nature. 2011 ; Vol. 479, No. 7372. pp. 232-236.
@article{fa4d243127ef470b8e27dad7cb7a74fc,
title = "Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders",
abstract = "Advanced age is the main risk factor for most chronic diseases and functional deficits in humans, but the fundamental mechanisms that drive ageing remain largely unknown, impeding the development of interventions that might delay or prevent age-related disorders and maximize healthy lifespan. Cellular senescence, which halts the proliferation of damaged or dysfunctional cells, is an important mechanism to constrain the malignant progression of tumour cells. Senescent cells accumulate in various tissues and organs with ageing and have been hypothesized to disrupt tissue structure and function because of the components they secrete. However, whether senescent cells are causally implicated in age-related dysfunction and whether their removal is beneficial has remained unknown. To address these fundamental questions, we made use of a biomarker for senescence, p16Ink4a, to design a novel transgene, INK-ATTAC, for inducible elimination of p16Ink4a-positive senescent cells upon administration of a drug. Here we show that in the BubR1 progeroid mouse background, INK-ATTAC removes p16Ink4a-positive senescent cells upon drug treatment. In tissues-such as adipose tissue, skeletal muscle and eye-in which p16Ink4a contributes to the acquisition of age-related pathologies, life-long removal of p16Ink4a-expressing cells delayed onset of these phenotypes. Furthermore, late-life clearance attenuated progression of already established age-related disorders. These data indicate that cellular senescence is causally implicated in generating age-related phenotypes and that removal of senescent cells can prevent or delay tissue dysfunction and extend healthspan.",
author = "Baker, {Darren J} and Tobias Wijshake and Tamar Tchkonia and LeBrasseur, {Nathan K} and Childs, {Bennett G.} and {Van De Sluis}, Bart and Kirkland, {James L} and {Van Deursen}, Jan",
year = "2011",
month = "11",
day = "10",
doi = "10.1038/nature10600",
language = "English (US)",
volume = "479",
pages = "232--236",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7372",

}

TY - JOUR

T1 - Clearance of p16 Ink4a-positive senescent cells delays ageing-associated disorders

AU - Baker, Darren J

AU - Wijshake, Tobias

AU - Tchkonia, Tamar

AU - LeBrasseur, Nathan K

AU - Childs, Bennett G.

AU - Van De Sluis, Bart

AU - Kirkland, James L

AU - Van Deursen, Jan

PY - 2011/11/10

Y1 - 2011/11/10

N2 - Advanced age is the main risk factor for most chronic diseases and functional deficits in humans, but the fundamental mechanisms that drive ageing remain largely unknown, impeding the development of interventions that might delay or prevent age-related disorders and maximize healthy lifespan. Cellular senescence, which halts the proliferation of damaged or dysfunctional cells, is an important mechanism to constrain the malignant progression of tumour cells. Senescent cells accumulate in various tissues and organs with ageing and have been hypothesized to disrupt tissue structure and function because of the components they secrete. However, whether senescent cells are causally implicated in age-related dysfunction and whether their removal is beneficial has remained unknown. To address these fundamental questions, we made use of a biomarker for senescence, p16Ink4a, to design a novel transgene, INK-ATTAC, for inducible elimination of p16Ink4a-positive senescent cells upon administration of a drug. Here we show that in the BubR1 progeroid mouse background, INK-ATTAC removes p16Ink4a-positive senescent cells upon drug treatment. In tissues-such as adipose tissue, skeletal muscle and eye-in which p16Ink4a contributes to the acquisition of age-related pathologies, life-long removal of p16Ink4a-expressing cells delayed onset of these phenotypes. Furthermore, late-life clearance attenuated progression of already established age-related disorders. These data indicate that cellular senescence is causally implicated in generating age-related phenotypes and that removal of senescent cells can prevent or delay tissue dysfunction and extend healthspan.

AB - Advanced age is the main risk factor for most chronic diseases and functional deficits in humans, but the fundamental mechanisms that drive ageing remain largely unknown, impeding the development of interventions that might delay or prevent age-related disorders and maximize healthy lifespan. Cellular senescence, which halts the proliferation of damaged or dysfunctional cells, is an important mechanism to constrain the malignant progression of tumour cells. Senescent cells accumulate in various tissues and organs with ageing and have been hypothesized to disrupt tissue structure and function because of the components they secrete. However, whether senescent cells are causally implicated in age-related dysfunction and whether their removal is beneficial has remained unknown. To address these fundamental questions, we made use of a biomarker for senescence, p16Ink4a, to design a novel transgene, INK-ATTAC, for inducible elimination of p16Ink4a-positive senescent cells upon administration of a drug. Here we show that in the BubR1 progeroid mouse background, INK-ATTAC removes p16Ink4a-positive senescent cells upon drug treatment. In tissues-such as adipose tissue, skeletal muscle and eye-in which p16Ink4a contributes to the acquisition of age-related pathologies, life-long removal of p16Ink4a-expressing cells delayed onset of these phenotypes. Furthermore, late-life clearance attenuated progression of already established age-related disorders. These data indicate that cellular senescence is causally implicated in generating age-related phenotypes and that removal of senescent cells can prevent or delay tissue dysfunction and extend healthspan.

UR - http://www.scopus.com/inward/record.url?scp=80855138775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80855138775&partnerID=8YFLogxK

U2 - 10.1038/nature10600

DO - 10.1038/nature10600

M3 - Article

C2 - 22048312

AN - SCOPUS:80855138775

VL - 479

SP - 232

EP - 236

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7372

ER -